… intestinal inflammation can predict clinical relapse and provide a noninvasive strategy to
manage inflammatory bowel disease. … of personalized medicine in inflammatory bowel disease. …

… too late in disease progression. Conventional drugs are the mainstay of current therapy for
inflammatory bowel diseases, but drug type, timing, and context must be optimized to manage …

… Crohn's disease (CD) and ulcerative colitis (UC) comprise a series of idiopathic and
heterogeneous inflammatory disorders … exact etiopathogenesis of inflammatory bowel disease …

… ABSTRACT Inflammatory bowel disease therapy can be … soon to be available for the medical
management of IBD. Although … of acute inflammatory bowel disease management, steroids …

… in the treatment of inflammatory bowel disease. Gastroenterology 1994;106:287–296. 8
Mary JY, Modigliani R: Development and Validation of an endoscopic index of the severity for …

… decades of active disease. The purpose of this review is to assess the economic impact of
inflammatory bowel disease and to consider issues of cost-effectiveness in clinical practice. …

… Crohn’s disease (CD) and ulcerative colitis (UC) are the … by the classification of inflammatory
bowel disease (IBD). While … and colon, whereas UC by definition affects only the colon. The …

… Clinical Services and Standards Committee of the British Society of Gastroenterology (BSG)
for clinicians and allied professionals caring for patients with inflammatory bowel disease in …

… The treatment of inflammatory bowel disease (IBD) is undergoing rapid and profound … how
to control the inflammatory process. These began with inflixumab therapy for Crohn's disease. …

… eventually require surgery, and about 25% of patients with ulcerative colitis require
colectomy. Treatment of ulcerative colitis is generally by corticosteroids for acute disease and …